Literature DB >> 294806

Penetration of erythromycin through respiratory mucosa. A study using secretory otitis media as a model.

L Sundberg, T Edén, S Ernstson, R Pahlitzsch.   

Abstract

This study is based upon the concept that the respiratory mucosa reacts in a uniform manner to an inflammatory stimulus. Secretory Otitis Media (SOM) may be used as a model to disclose some aspects of antibiotic penetration. Erythromycin was given for different periods of time to 108 cases of SOM where myringotomy was indicated. The middle ear effusion was aspirated and blood samples were obtained simultaneously. The concentration of erythromycin was determined by microbiological procedures. Erythromycin penetrated into the middle ear effusion. After the fourth dose the concentration was at the same level as the plasma peak level. The elimination of the drug from the middle ear secretion was considerably prolonged compared with the rapid elimination from plasma. This implies that erythromycin attains a steady state in the middle ear effusion with concentrations equal to the plasma peak level.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 294806     DOI: 10.3109/00016487909124940

Source DB:  PubMed          Journal:  Acta Otolaryngol Suppl        ISSN: 0365-5237


  4 in total

Review 1.  Clinical pharmacokinetic properties of the macrolide antibiotics. Effects of age and various pathophysiological states (Part II).

Authors:  P Periti; T Mazzei; E Mini; A Novelli
Journal:  Clin Pharmacokinet       Date:  1989-05       Impact factor: 6.447

2.  The penetration of erythromycin into Waldeyer's ring--tonsil and adenoid tissue.

Authors:  L Sundberg; T Edén; S Ernstson
Journal:  Infection       Date:  1982       Impact factor: 3.553

3.  In vitro activity of orally administered antimicrobial agents against Haemophilus influenzae recovered from children monitored longitudinally in a group day-care center.

Authors:  M J George; B Kitch; F W Henderson; P H Gilligan
Journal:  Antimicrob Agents Chemother       Date:  1991-10       Impact factor: 5.191

4.  The penetration of erythromycin into the middle ear.

Authors:  L Sundberg; T Edén; S Ernstson
Journal:  Infection       Date:  1982       Impact factor: 3.553

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.